CardioDx strikes deal to bring artery disease assay to India

04/26/2013 | GenomeWeb Daily News (free registration)

CardioDx has agreed to allow Core Diagnostics India to distribute its Corus CAD diagnostic system in India for undisclosed terms. The blood-based gene expression test, which was released as a laboratory-developed assay in 2009, is intended to screen patients showing symptoms of obstructive coronary artery disease.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA